Bibliographic Details
| Title: |
Bioequivalence, safety, and tolerability of imatinib tablets compared with capsules. |
| Authors: |
Nikolova Z; Novartis Oncology, Basel, Switzerland. zariana.nikolova@pharma.novartis.com, Peng B, Hubert M, Sieberling M, Keller U, Ho YY, Schran H, Capdeville R |
| Source: |
Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2004 May; Vol. 53 (5), pp. 433-8. |
| Publication Type: |
Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial |
| Journal Info: |
Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Print Cited Medium: Print ISSN: 0344-5704 (Print) Linking ISSN: 03445704 NLM ISO Abbreviation: Cancer Chemother Pharmacol Subsets: MEDLINE |
| Database: |
MEDLINE Ultimate |
